Pharmsville Co., Ltd. (KOSDAQ:318010)
South Korea · Delayed Price · Currency is KRW 3,420.00
-25.00 (-0.73%)
At close: Jan 23, 2026
Pharmsville Revenue
Pharmsville had revenue of 3.37B KRW in the quarter ending September 30, 2025, a decrease of -20.69%. This brings the company's revenue in the last twelve months to 13.36B, down -25.46% year-over-year. In the year 2024, Pharmsville had annual revenue of 16.72B, down -21.83%.
Revenue (ttm)
13.36B
Revenue Growth
-25.46%
P/S Ratio
1.98
Revenue / Employee
477.13M
Employees
28
Market Cap
26.43B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 16.72B | -4.67B | -21.83% |
| Dec 31, 2023 | 21.39B | -4.72B | -18.07% |
| Dec 31, 2022 | 26.11B | -12.91B | -33.09% |
| Dec 31, 2021 | 39.03B | -381.05M | -0.97% |
| Dec 31, 2020 | 39.41B | 9.46B | 31.57% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hurum | 95.37B |
| GeneBioTech Co. ,Ltd | 92.28B |
| ChoA Pharmaceutical Co., LTD. | 60.50B |
| WooGene B&G | 54.77B |
| Seoul Pharma | 52.43B |
| Union Korea Pharm | 33.83B |
| Daesung Microbiological Labs. | 25.86B |
| BIFIDO | 18.65B |